• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊曲康唑和胺碘酮联合治疗对人干细胞源性心肌细胞感染具有高度疗效。

A Combination of Itraconazole and Amiodarone Is Highly Effective against Infection of Human Stem Cell-Derived Cardiomyocytes.

机构信息

California Institute for Medical Research, San Jose, California.

Animal Hospital of Smithson Valley, Spring Branch, Texas.

出版信息

Am J Trop Med Hyg. 2019 Aug;101(2):383-391. doi: 10.4269/ajtmh.19-0023.

DOI:10.4269/ajtmh.19-0023
PMID:31219005
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6685576/
Abstract

is the etiologic agent of Chagas disease (CD), which can result in severe cardiomyopathy. is endemic to the Americas, and of particular importance in Latin America. In the United States and other non-endemic countries, rising case numbers have also been observed. The currently used drugs are benznidazole (BNZ) and nifurtimox, which have limited efficacy during chronic infection. We repurposed itraconazole (ICZ), originally an antifungal, in combination with amiodarone (AMD), an antiarrhythmic, with the goal of interfering with infection. Human pluripotent stem cells (hiPSCs) were differentiated into cardiomyocytes (hiPSC-CMs). Vero cells or hiPSC-CMs were infected with trypomastigotes of the II or I strain in the presence of ICZ and/or AMD. After 48 hours, cells were Giemsa stained, and infection and multiplication were evaluated microscopically. infection and multiplication were evalutated also by electron microscopy. BNZ was used as a reference compound. Cell metabolism in the presence of test substances was assessed. Itraconazole and AMD showed strain- and dose-dependent interference with infection and multiplication in Vero cells or hiPSC-CMs. Combinations of ICZ and AMD were more effective against than the single substances, or BNZ, without affecting host cell metabolism, and better preserving host cell integrity during infection. Our in vitro data in hiPSC-CMs suggest that a combination of ICZ and AMD might serve as a treatment option for CD in patients, but that different responses due to strain differences have to be taken into account.

摘要

是恰加斯病(CD)的病原体,可导致严重的心肌病。它在美洲流行,在拉丁美洲尤为重要。在美国和其他非流行国家,也观察到病例数量上升。目前使用的药物是苯硝唑(BNZ)和硝呋替莫,它们在慢性感染期间疗效有限。我们重新利用了伊曲康唑(ICZ),最初是一种抗真菌药,与胺碘酮(AMD)联合使用,目的是干扰感染。人多能干细胞(hiPSCs)分化为心肌细胞(hiPSC-CMs)。在存在 ICZ 和/或 AMD 的情况下,用 II 或 I 株的锥虫感染 Vero 细胞或 hiPSC-CMs。48 小时后,用吉姆萨染色,用显微镜评估感染和增殖情况。还通过电子显微镜评估感染和增殖。使用苯硝唑作为参考化合物。评估测试物质存在时的细胞代谢。伊曲康唑和胺碘酮显示出对 Vero 细胞或 hiPSC-CMs 中感染和增殖的菌株和剂量依赖性干扰。ICZ 和 AMD 的组合比单一物质或苯硝唑更有效,而不影响宿主细胞代谢,并在感染过程中更好地保持宿主细胞完整性。我们在 hiPSC-CMs 中的体外数据表明,ICZ 和 AMD 的组合可能是治疗患者 CD 的一种选择,但由于菌株差异,需要考虑不同的反应。

相似文献

1
A Combination of Itraconazole and Amiodarone Is Highly Effective against Infection of Human Stem Cell-Derived Cardiomyocytes.伊曲康唑和胺碘酮联合治疗对人干细胞源性心肌细胞感染具有高度疗效。
Am J Trop Med Hyg. 2019 Aug;101(2):383-391. doi: 10.4269/ajtmh.19-0023.
2
Vismione B Interferes with Infection of Vero Cells and Human Stem Cell-Derived Cardiomyocytes.Vismione B 干扰 Vero 细胞和人干细胞来源心肌细胞的感染。
Am J Trop Med Hyg. 2019 Dec;101(6):1359-1368. doi: 10.4269/ajtmh.19-0350.
3
Experimental Combination Therapy with Amiodarone and Low-Dose Benznidazole in a Mouse Model of Trypanosoma cruzi Acute Infection.实验组合疗法用胺碘酮和低剂量苯硝唑在克氏锥虫急性感染的小鼠模型中。
Microbiol Spectr. 2022 Feb 23;10(1):e0185221. doi: 10.1128/spectrum.01852-21. Epub 2022 Feb 9.
4
Benznidazole and amiodarone combined treatment attenuates cytoskeletal damage in -infected cardiac cells.联合应用苯硝唑和胺碘酮治疗可减轻感染心肌细胞的细胞骨架损伤。
Front Cell Infect Microbiol. 2022 Aug 25;12:975931. doi: 10.3389/fcimb.2022.975931. eCollection 2022.
5
Preclinical evaluation of combined therapy with amiodarone and low-dose benznidazole in a mouse model of chronic Trypanosoma cruzi infection.在慢性克氏锥虫感染的小鼠模型中,评价胺碘酮与低剂量苯硝唑联合治疗的临床前评估。
Biomed Pharmacother. 2024 Jun;175:116742. doi: 10.1016/j.biopha.2024.116742. Epub 2024 May 15.
6
Benznidazole/Itraconazole Combination Treatment Enhances Anti-Trypanosoma cruzi Activity in Experimental Chagas Disease.苯硝唑/伊曲康唑联合治疗增强实验性恰加斯病中抗克鲁斯锥虫的活性。
PLoS One. 2015 Jun 15;10(6):e0128707. doi: 10.1371/journal.pone.0128707. eCollection 2015.
7
Amiodarone inhibits Trypanosoma cruzi infection and promotes cardiac cell recovery with gap junction and cytoskeleton reassembly in vitro.胺碘酮可抑制克氏锥虫感染,并通过体外缝隙连接和细胞骨架重排促进心肌细胞恢复。
Antimicrob Agents Chemother. 2011 Jan;55(1):203-10. doi: 10.1128/AAC.01129-10. Epub 2010 Nov 15.
8
Evaluation of in vitro anti-Trypanosoma cruzi activity of medications benznidazole, amiodarone hydrochloride, and their combination.药物苯硝唑、盐酸胺碘酮及其组合对克氏锥虫的体外抗虫活性评估。
Rev Soc Bras Med Trop. 2018 Jan-Feb;51(1):52-56. doi: 10.1590/0037-8682-0285-2017.
9
Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole.胺碘酮具有内在的抗克氏锥虫活性,并与泊沙康唑协同发挥作用。
J Med Chem. 2006 Feb 9;49(3):892-9. doi: 10.1021/jm050691f.
10
Discovery of a new eugenol-benznidazole hybrid active against different evolutive stages of Trypanosoma cruzi.发现一种对克氏锥虫不同发育阶段具有活性的新型丁香酚-苯硝唑杂合物。
Bioorg Chem. 2025 Jan;154:107993. doi: 10.1016/j.bioorg.2024.107993. Epub 2024 Nov 22.

引用本文的文献

1
Amiodarone and Ravuconazole Combination Potentiates Chemotherapy against Drug-Resistant Trypanosoma cruzi Strains.胺碘酮与雷夫康唑联合用药增强对耐药克氏锥虫菌株的化疗效果。
ACS Omega. 2025 May 16;10(21):21648-21661. doi: 10.1021/acsomega.5c00996. eCollection 2025 Jun 3.
2
Repurposing of Amiodarone for treatment of muscle phase of experimental trichinellosis spiralis.将胺碘酮重新用于治疗实验性旋毛虫病的肌肉期。
J Parasit Dis. 2025 Jun;49(2):419-425. doi: 10.1007/s12639-024-01763-2. Epub 2024 Dec 6.
3
Transcriptomic analysis of the adaptation to prolonged starvation of the insect-dwelling epimastigotes.昆虫寄生的前鞭毛体对长期饥饿适应的转录组分析。
Front Cell Infect Microbiol. 2023 Apr 6;13:1138456. doi: 10.3389/fcimb.2023.1138456. eCollection 2023.
4
Benznidazole and amiodarone combined treatment attenuates cytoskeletal damage in -infected cardiac cells.联合应用苯硝唑和胺碘酮治疗可减轻感染心肌细胞的细胞骨架损伤。
Front Cell Infect Microbiol. 2022 Aug 25;12:975931. doi: 10.3389/fcimb.2022.975931. eCollection 2022.
5
Effects of amiodarone, amioder, and dronedarone on Trichomonas vaginalis.胺碘酮、胺碘尔和决奈达隆对阴道毛滴虫的作用。
Parasitol Res. 2022 Jun;121(6):1761-1773. doi: 10.1007/s00436-022-07521-8. Epub 2022 Apr 18.
6
Antiparasitic Properties of Cardiovascular Agents against Human Intravascular Parasite .心血管药物对人体血管内寄生虫的抗寄生虫特性
Pharmaceuticals (Basel). 2021 Jul 16;14(7):686. doi: 10.3390/ph14070686.
7
Review on Experimental Treatment Strategies Against .关于针对……的实验性治疗策略的综述
J Exp Pharmacol. 2021 Mar 31;13:409-432. doi: 10.2147/JEP.S267378. eCollection 2021.
8
The Stem Cell Revolution Revealing Protozoan Parasites' Secrets and Paving the Way towards Vaccine Development.干细胞革命:揭示原生动物寄生虫的秘密并为疫苗开发铺平道路
Vaccines (Basel). 2021 Jan 31;9(2):105. doi: 10.3390/vaccines9020105.
9
Beyond Family: Modeling Non-hereditary Heart Diseases With Human Pluripotent Stem Cell-Derived Cardiomyocytes.超越家族:利用人类多能干细胞衍生的心肌细胞模拟非遗传性心脏病
Front Physiol. 2020 Apr 22;11:384. doi: 10.3389/fphys.2020.00384. eCollection 2020.
10
Vismione B Interferes with Infection of Vero Cells and Human Stem Cell-Derived Cardiomyocytes.Vismione B 干扰 Vero 细胞和人干细胞来源心肌细胞的感染。
Am J Trop Med Hyg. 2019 Dec;101(6):1359-1368. doi: 10.4269/ajtmh.19-0350.

本文引用的文献

1
Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes as a Model to Study Trypanosoma cruzi Infection.使用人诱导多能干细胞衍生心肌细胞作为研究克氏锥虫感染的模型。
Stem Cell Reports. 2019 Jun 11;12(6):1232-1241. doi: 10.1016/j.stemcr.2019.04.017. Epub 2019 May 16.
2
Evolution, Systematics, and Biogeography of the Triatominae, Vectors of Chagas Disease.锥蝽科,即恰加斯病的传播媒介:进化、系统学和生物地理学。
Adv Parasitol. 2018;99:265-344. doi: 10.1016/bs.apar.2017.12.002.
3
Evaluation of in vitro anti-Trypanosoma cruzi activity of medications benznidazole, amiodarone hydrochloride, and their combination.药物苯硝唑、盐酸胺碘酮及其组合对克氏锥虫的体外抗虫活性评估。
Rev Soc Bras Med Trop. 2018 Jan-Feb;51(1):52-56. doi: 10.1590/0037-8682-0285-2017.
4
New Insights into the Immunobiology of Mononuclear Phagocytic Cells and Their Relevance to the Pathogenesis of Cardiovascular Diseases.单核吞噬细胞免疫生物学及其与心血管疾病发病机制相关性的新见解。
Front Immunol. 2018 Jan 9;8:1921. doi: 10.3389/fimmu.2017.01921. eCollection 2017.
5
Experimental and Clinical Treatment of Chagas Disease: A Review.恰加斯病的实验与临床治疗综述
Am J Trop Med Hyg. 2017 Nov;97(5):1289-1303. doi: 10.4269/ajtmh.16-0761. Epub 2017 Oct 10.
6
Trypanosoma cruzi genetic diversity: Something new for something known about Chagas disease manifestations, serodiagnosis and drug sensitivity.克氏锥虫的遗传多样性:关于恰加斯病表现、血清学诊断和药物敏感性已知情况的新进展。
Acta Trop. 2018 Aug;184:38-52. doi: 10.1016/j.actatropica.2017.09.017. Epub 2017 Sep 21.
7
Lack of Efficacy of Liposomal Amphotericin B Against Acute and Chronic Infection in Mice.脂质体两性霉素B对小鼠急慢性感染缺乏疗效
Am J Trop Med Hyg. 2017 Oct;97(4):1141-1146. doi: 10.4269/ajtmh.16-0975. Epub 2017 Aug 18.
8
Challenges in the chemotherapy of Chagas disease: Looking for possibilities related to the differences and similarities between the parasite and host.恰加斯病化疗面临的挑战:探寻与寄生虫和宿主异同相关的可能性。
World J Biol Chem. 2017 Feb 26;8(1):57-80. doi: 10.4331/wjbc.v8.i1.57.
9
Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers: The STOP-CHAGAS Trial.苯硝唑和泊沙康唑消除无症状 T. cruzi 携带者寄生虫:STOP-CHAGAS 试验。
J Am Coll Cardiol. 2017 Feb 28;69(8):939-947. doi: 10.1016/j.jacc.2016.12.023.
10
(Agent of Chagas Disease) in Sympatric Human and Dog Populations in "Colonias" of the Lower Rio Grande Valley of Texas.德克萨斯州下里奥格兰德河谷“移民定居点”中同域分布的人类和犬类群体中的(恰加斯病病原体)
Am J Trop Med Hyg. 2017 Apr;96(4):805-814. doi: 10.4269/ajtmh.16-0789. Epub 2017 Feb 6.